Meet the Authors SESSION 2- Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS – Medical Affairs Professional Society

Meet the Authors SESSION 2- Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS

In July, MAPS partnered with APPA Australia , IFAPP Academy and the Medical Science Liaison Society to produce a joint position paper on the role of Medical Science Liaisons in the pharmaceutical industry. September 1st, we hosted a discussion with some of the paper authors to discuss consensus on best practices.

In part two of that first discussion, you’ll hear from more of the authors on:

What is an MSL or Field Medical?
How are these roles different from traditional field roles?
What does the future look like?
How did COVID change things?
What gaps remain for these roles?
How really do we measure outcomes at a patient level?

Moderator: Robin Winter-Sperry, MD

Moderator: Robin Winter-Sperry, MD

MAPS Director and Membership Committee Chair, Global MSL Lead, Ipsen

Speaker: Donna Holder, PharmD

Speaker: Donna Holder, PharmD

Senior Director, Global MSL Excellence Oncology, Daiichi Sankyo

Speaker: Ralph Rewers, PharmD

Speaker: Ralph Rewers, PharmD

Senior Director, Head Global MSL Excellence – Onco, AstraZeneca

Speaker: Matthew Britland

Speaker: Matthew Britland

Medical Director, Amgen, V.P of APPA

Read the Full Position Statement Here

Watch Webinar:

Watch Interview with Robin Winter-Sperry & Matthew Britland: